NIH-funded research NIH-funded research

Developing treatments to reverse tooth decay in young children

Official title: A multiscale approach to develop and apply fluoride efflux inhibitors to reverse oral dysbiosis and eliminate early childhood caries

Funded at University of Michigan at Ann Arbor · NIH-10990788 · Data updated 2026-11-12

This study is working on a new way to help young kids with tooth decay by creating special treatments that make fluoride work better against bad bacteria in their mouths.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Michigan at Ann Arbor
NIH-funded
Lab location1 site (Ann Arbor, United States)
Project startSeptember 12, 2024
Project endJune 30, 2029
Funding year2024
Award (this year)$1,157,291
NIH project number1RM1DE034220-01
Project IDNIH-10990788 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are children aged 0-11 years who are at risk for or currently experiencing early childhood caries.

Less likely to help

Patients who are older than 11 years or those without any signs of dental caries may not benefit from this research.

What this research studies

This research focuses on addressing early childhood caries (ECC), a significant health issue affecting millions of children worldwide. The project aims to develop fluoride efflux inhibitors that can help reverse oral dysbiosis, which is the imbalance of harmful and beneficial bacteria in the mouth. By targeting specific proteins in pathogenic microbes, the research seeks to enhance the effectiveness of fluoride in preventing tooth decay. This innovative approach combines expertise from various fields, including structural biology and cariology, to create a more effective treatment for young children.

Why it matters

Potential benefit: If successful, this research could significantly reduce the incidence of tooth decay in children, improving their overall health and quality of life.

How similar studies have gone: Previous research has shown promise in targeting microbial dynamics in oral health, suggesting that this approach could lead to significant advancements in caries treatment.

Where this research is happening

  • University of Michigan at Ann Arbor
    Ann Arbor, United States
    Active

Researchers

  • Principal investigator: Stockbridge, Randy B. — University of Michigan at Ann Arbor
  • Study coordinator: Stockbridge, Randy B.

Related research

Other NIH-funded projects on the same topics.

  • Microbial Dysbiosis and Its Role in Pancreatic Cancer

    A doctor-researcher team at Northwestern University is studying how gut bacteria influence pancreatic cancer and its response to immunotherapy to find new ways to help patients.

    NIH research Northwestern University · Chicago, United States · NIH-11624054

  • From Symbiosis to Dysbiosis: How Resolving Inflammation Could Restore Your Mouth’s Balance

    This grant explores how turning off the harmful inflammation in periodontitis and promoting natural healing could help restore the mouth’s healthy balance.

    NIH research Ada Forsyth Institute, INC. · Somerville, UNITED STATES · NIH-11621747

  • Antibiotics, gut health, and skin reactions in kids

    A small study in children will look at whether antibiotic use and gut bacteria play a role in hives and related symptoms that children sometimes get after antibiotics.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11603169

  • Novel therapeutic to protect the gut after radiation

    A new GI-directed treatment given after radiation exposure may reduce gut damage and improve survival in people exposed to high-dose radiation.

    NIH research Columbia University Health Sciences · New York, United States · NIH-11572662

  • A new GI-focused treatment to reduce radiation damage after exposure

    A potential GI-targeted therapy given after radiation exposure may help protect the gut and improve survival in people affected by radiation injuries.

    NIH research Columbia University Health Sciences · New York, United States · NIH-11572658

  • How a mouth bacterium might fuel gum disease and heart risk

    A small study will look at how a bacterium in the mouth that makes a reactive chemical (methylglyoxal) could drive gum inflammation and changes in the mouth’s bacteria, possibly linking to heart disease.

    NIH research State University of New York at Buffalo · Amherst, United States · NIH-11564245

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.